571
Stegeman, Raymond, Nijman, Maaike, Breur, Johannes M P J, Groenendaal, Floris, Haas, Felix, Derks, Jan B, Nijman, Joppe, van Beynum, Ingrid M, Taverne, Yannick J H J, Bogers, Ad J J C, Helbing, Willem A, de Boode, Willem P, Bos, Arend F, Berger, Rolf M F, Accord, Ryan E, Roes, Kit C B, de Wit, G Ardine, Jansen, Nicolaas J G, Benders, Manon J N L
Veröffentlicht in: CRUCIAL trial consortium , Stegeman , R , Nijman , M , Breur , J M P J , Groenendaal , F , Haas , F , Derks , J B , Nijman , J , van Beynum , I M , Taverne , Y J H J , Bogers , A J J C , Helbing , W A , de Boode , W P , Bos , A F , Berger , R M F , Accord , R E , Roes , K C B , de Wit , G A , Jansen , N J G & Benders , M J N L 2022 , ' CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL) : study protocol of a phase III, randomized, quadruple-blinded, placebo-controlled, Dutch multicenter trial ' , Trials , vol. 23 , no. 1 , 174 . https://doi.org/10.1186/s13063-022-06098-y;
2022
Veröffentlicht in: CRUCIAL trial consortium , Stegeman , R , Nijman , M , Breur , J M P J , Groenendaal , F , Haas , F , Derks , J B , Nijman , J , van Beynum , I M , Taverne , Y J H J , Bogers , A J J C , Helbing , W A , de Boode , W P , Bos , A F , Berger , R M F , Accord , R E , Roes , K C B , de Wit , G A , Jansen , N J G & Benders , M J N L 2022 , ' CeRebrUm and CardIac Protection with ALlopurinol in Neonates with Critical Congenital Heart Disease Requiring Cardiac Surgery with Cardiopulmonary Bypass (CRUCIAL) : study protocol of a phase III, randomized, quadruple-blinded, placebo-controlled, Dutch multicenter trial ' , Trials , vol. 23 , no. 1 , 174 . https://doi.org/10.1186/s13063-022-06098-y;
2022
572
573
574
575
576
577
578
Gant, C.M., Soedamah-Muthu, S.S., Binnenmars, S.H., Bakker, S.J.L., Navis, G., Laverman, G.D.
Veröffentlicht in: Gant , C M , Soedamah-Muthu , S S , Binnenmars , S H , Bakker , S J L , Navis , G & Laverman , G D 2018 , ' Higher dietary magnesium intake and higher magnesium status are associated with lower prevalence of coronary heart disease in patients with type 2 diabetes ' , Nutrients , vol. 10 , no. 3 , 307 . https://doi.org/10.3390/nu10030307;
2018
Veröffentlicht in: Gant , C M , Soedamah-Muthu , S S , Binnenmars , S H , Bakker , S J L , Navis , G & Laverman , G D 2018 , ' Higher dietary magnesium intake and higher magnesium status are associated with lower prevalence of coronary heart disease in patients with type 2 diabetes ' , Nutrients , vol. 10 , no. 3 , 307 . https://doi.org/10.3390/nu10030307;
2018
579
580